375823-41-9

Interleukin inhibitor:
Treatment of rheumatoid arthritis in combination with methotrexate

Potentially hazardous interactions with other drugs
Live vaccines: avoid concomitant administration

Tocilizumab undergoes biphasic elimination from the circulation. The total clearance of tocilizumab is concentration-dependent and is the sum of the linear and non-linear clearance. The concentration-dependent non-linear clearance plays a major role at low tocilizumab concentrations. Once the non-linear clearance pathway is saturated, at higher tocilizumab concentrations, clearance is mainly determined by the linear clearance.

Store at -80°C